Term
|
Definition
Muscarinic Agonist Resistant to AchE, no nicotinic R activity, Use: GI: incr contractile force in smooth muscle (M3), Incr smooth m. contraction in bladder Tox: don't use with an obstruction bc rupture can occur
|
|
|
Term
|
Definition
Muscarinic agonist, PNS--contracts ciliary m-->accomodation for near objects, relax suspensory ligs-->convex lens, drain aq. humor, decr intraocular P. res to AchE, lim nicotinic R activity, Use: Xerostomia--facilitates lacrimal and salivary secretions. Narrow angle glaucoma. Reverses mydriasis from atropine Tox: in athsma incr bronchial constriction/secretion. Incr acid secretion in peptic ulcer, abd cramps, can't focus on far objects, salivation, sweating.
|
|
|
Term
|
Definition
Muscarinic agonist res to AchE, great activity at Muscarinic R, increases nicotinic R activity Toxicity: blurred vision, dry mouth, constipation, indigestion, Abd pain
|
|
|
Term
|
Definition
Muscarinic antagonist--get anti PNS effects plant alkaloid, blocks PNS-like stuff, so blocks Ach action on muscarinic Use: Irrit. bowel syndrome-reduces GI tone and motility, mydriasis, retina exam Tox: mydriasis-->cyclopegia since vision is locked at distance and can't focus close
|
|
|
Term
|
Definition
|
|
Term
|
Definition
Muscarinic antagonist--deriv of atropine has M1 selectivity Use: peptic ulcers, preferred over Atropine bc of selectivity
|
|
|
Term
|
Definition
Muscarinic antagonist--derived from atropine Use: COPD, athsma caused by cigarette smoke Tox: dry mouth with inhalation
|
|
|
Term
|
Definition
Nicotinic antagonist (ganglionic blocking) Use: limited, chronic hypertension, CV regulation
|
|
|
Term
|
Definition
Non depolarizing drug, competitive nicotinic antagonist (NMJ), competes with Ach for binding at nicotinc R, motor weakness giving way to flaccid paralysis(sm rapid muscles first) Use: immobilize/paralyze wild animals, long duration of action, relaxation of skel m to facilitate operative manipulations (esp abdom)
|
|
|
Term
|
Definition
Depolarization blocker(NMJ)--init opens Ach channels, but bc res to ACh, it lasts longer in clerft-->long depolarization. Brief repetitive excitation--transient m fasciculations, block NMJ transmission, flaccid paralysis. Use: office procedures bc reversed quickly, intubation, brochoscopy, esophagoscopy |
|
|
Term
|
Definition
- Ach release blocker
- Use: focal dystonia in dermatology
|
|
|
Term
|
Definition
- Ach Inhibitor
- MOA: Carbamate ester, covalent, longer lived (6hr)
- Use: MG-incr response of myasthenic m. to repetitive n. impulses, preserves endog Ach, prophylactic for AChE inhib toxicity
|
|
|
Term
|
Definition
- AChE inhibitor
- MOA: Carbamate ester, covalent bonds--Hydration step can take 6 hrs, so good for keeping Ach in cleft.
- Use: MG--incr response of myasthenic m to repetitive n impulses, preserve endogenous ACh, stepwise incr in dose to find optimal
|
|
|
Term
|
Definition
- AchE Inhibitor
- MOA:4nary alcohol, binds electrostaticly so rapidly diffuses off (2-10 min)
- Uses: Tensilon test for MG (if muscle strength improves with test then MG diagnosis made)
|
|
|
Term
|
Definition
- AchE inhibitor
- MOA: Carbamate ester, covalent, long lived (6hr)
- Use: MG
|
|
|
Term
Malathion, Parathion, Echothiophate |
|
Definition
- AChE inhibitors
- organophosphates, Extremely stable, 100s of hours, Aging, irreversible.
- Tox: too irreversible and can't adjust the dose
|
|
|
Term
|
Definition
- Regenerator of AchE
- MOA: can reverse the organophosphate binding, modifies binding and reactivates AChE
- Use: can be used prophylactically
|
|
|